Revolution Medicines, Inc. (RVMD)
NASDAQ: RVMD · Real-Time Price · USD
204.86
-0.25 (-0.12%)
Sep 15, 2026, 4:00 PM EDT - Market closed
Revolution Medicines Market Cap
Revolution Medicines has a market cap or net worth of $43.91 billion as of September 15, 2026. Its market cap has increased by 404.60% in one year.
Market Cap
43.91B
Enterprise Value
41.16B
1-Year Change
404.60%
Ranking
Category
Stock Price
$204.86
ChartMarket Cap Chart
Since February 13, 2020, Revolution Medicines's market cap has increased from $1.64B to $43.91B, an increase of 2,570.09%. That is a compound annual growth rate of 64.59%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 15, 2026 | 43.91B | 185.16% |
| Dec 31, 2025 | 15.40B | 90.50% |
| Dec 31, 2024 | 8.08B | 71.26% |
| Dec 29, 2023 | 4.72B | 123.15% |
| Dec 30, 2022 | 2.11B | 14.03% |
| Dec 31, 2021 | 1.85B | -29.43% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Feb 13, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Regeneron Pharmaceuticals | 77.30B |
| argenx SE | 62.00B |
| Moderna | 57.40B |
| BeOne Medicines AG | 39.40B |
| Royalty Pharma | 33.62B |
| Alnylam Pharmaceuticals | 31.88B |
| Roivant Sciences | 28.53B |
| Insmed | 26.19B |